5Chrawford JM. Bilirubin metabolism and the pathophysiology of jaundice.In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. 9th ed. Philadelphia: USA. Lippincott Williams and Wilkins,2003. 167-220.
6Raijmakers MTM, Jansen PLM, Steegers EAP, et al. Association of human liver bilirubin UDP-glucuronyhransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol, 2000,33 : 348-351.
7Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirttbin uridine diphosphoglucuronate glucuronosyl-transferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.Hum Murat, 2000,16:297-306.
8Borlak J, Thum T, Landt O, et al. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia( Gilbert's syndrome) in healthy subjects.Hepatology, 2000, 32:792-795.
1Chowdhurg NR, Arias IM, Wolkoff AW, et al. Disorders of bilirubin metabolism. In: Arias IM, Boyer JL, Chiasari FV, et al, eds. The liver:biology and pathobioloby. 4th ed. Philadelphia: USA. Lippincot Williams and Wilkins, 2001. 291-310.
2Chrawford JM. Bilirubin metabolism and the pathophysiology of jaundice. In: Schiff ER, Sorrell MF, Maddrey WC eds. Schiff's diseases of the liver . 9th ed. Philadelphia: USA. Lippincott Williams and Wilkins, 2003. 167-220.
3Owens IS, Ritter JK, Yeatman MT, et al. The noval UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UOP glucuronosyltransferase isozymes with a common carboxyl terminus. J Pharmacokin Biopharm, 1996,24: 491-508.
4Tiribelli C, Ostrow JD. New concepts in bilirubin and jaundice. Hepatology, 1996,24: 1296-1308.
5Tukey PH, Strassburg CP. Human UDG-glucuronosytransferases:metabolism, expression and disease. Annu Rev Pharmacol Toxicol,2000,40: 581-616.
6Traunet M, Meier PJ, Boyer JL. Molecular regulation of hepatocellular transport system in cholestasis. J Hepatol, 1999, 31:165-178.
7Keppler D, Ronig J, Nines A. Conjugated export pumps of the multidrug resistance protein(MRP) family in liver. In: Arias IM, Boyer JL, Chisari FV, et al, eds. The Liver: Biology and Phathobiology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 200
9Bohan A, Boyer JL. Mechamisms of hepatic transport of drugs. Semin Liver Dis, 2002, 22:123-133.
10Boyer JL. Moleculal mechanisms of bile formation and cholestasis. In: 2002 AASLD postgraduate course: Mechamism of acute and chronic liver disease, Boston, 2002, 5-10.
